Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Invesco CurrencyShares Australian Dollar Trust (FXA)

Invesco CurrencyShares Australian Dollar Trust adds Matthew Casaccia to sponsor board

Neutral Impact 2 of 5 leadership Written later

On August 3, 2026, Matthew Casaccia was appointed to the board of managers of Invesco Specialized Products, LLC, the sponsor of the Invesco CurrencyShares Australian Dollar Trust (FXA), effective at the close of business that day. He replaces Jordan Krugman, whose resignation from the sponsor and its affiliates, including his board seat, takes effect at the same time. The change concerns the sponsor's governance and does not describe any change to the trust's operations.

Key points

  • Matthew Casaccia appointed to the sponsor's board effective August 3, 2026
  • Casaccia is Senior Director of Financial Planning and Analysis at Invesco Ltd, with 17 years at the firm
  • Jordan Krugman resigned from all positions at the sponsor and its affiliates, effective the same day
  • Filing states the board appointment is not tied to any stated change in trust operations

The filing

CompanyInvesco CurrencyShares Australian Dollar Trust (FXA)
Form8-K, current report
Filed with the SECAug 3, 2026, 4:07 PM ET
Accession number0001193125-26-330559

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.